NCT06098144 is a Phase 4 clinical trial of Nicorette in Smoking Cessation, sponsored by University of Miami.

Who is sponsoring NCT06098144?

NCT06098144 is sponsored by University of Miami.

What drugs are being tested in NCT06098144?

Interventions in NCT06098144: Nicorette, Tobacco Quit-line, Brief Behavioral Counseling, Intensive Behavioral Counseling.

What condition does NCT06098144 study?

NCT06098144 studies Smoking Cessation, Tobacco Use Cessation, Tobacco Smoking.

Is NCT06098144 still recruiting?

NCT06098144 is currently recruiting now. Last updated 3 September 2025.

Last reviewed 2025-09-03 · How we verify

NCT06098144

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Smoking Cessation Program in the Construction Sector

Recruiting now Phase 4 Last updated 3 September 2025

What this trial tests

Phase 4 trial testing Nicorette in Smoking Cessation in 608 participants. Currently enrolling.

Timeline

10 April 2024

Primary endpoint
28 February 2027

28 February 2027

Quick facts

Lead sponsor	University of Miami
Phase	Phase 4
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	608
Start date	10 April 2024
Primary completion	28 February 2027
Estimated completion	28 February 2027
Sites	1 location across United States

Drugs / interventions tested

Nicorette (NICOTINE) — full drug profile →
Tobacco Quit-line
Brief Behavioral Counseling
Intensive Behavioral Counseling

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →
Tobacco Use Cessation — all drugs for Tobacco Use Cessation →
Tobacco Smoking — all drugs for Tobacco Smoking →

Sponsor

University of Miami

Who can join

18 and older, any sex, with Smoking Cessation or Tobacco Use Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Empowering safety managers to champion the implementation of smoking cessation services in the construction industry: Protocol for a sequential multiple assignment randomized trial.
Asfar T, Lee DJ, Salloum RG, LeLaurin JH, et al · · 2025 · PMID 40489501 · DOI 10.1371/journal.pone.0324717

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other University of Miami trials

Trials by the same sponsor.

NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06098144 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 3 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06098144.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing